Leptomeningeal Gadolinium Enhancement in Autoimmune GFAP Astrocytopathy
Citation Manager Formats
Make Comment
See Comments

Article Information
- First Published March 11, 2022.
Article Versions
- Previous version (March 11, 2022 - 12:45).
- You are viewing the most recent version of this article.
Author Disclosures
- Federica Azzolini, MD*,
- Antonio Farina, MD*,
- Matteo Gastaldi, MD, PhD,
- Alessandro Barilaro, MD, PhD,
- Valentina Scotti, MD,
- Giorgia Falchetti, MD,
- Enrico Fainardi, MD,
- Marco Moretti, MD and
- Luca Massacesi, MD
- Federica Azzolini, MD*,
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Antonio Farina, MD*,
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Matteo Gastaldi, MD, PhD,
<br>Advisory Board for Roche and UBC<br>
NONE
<br>Honoraria from Roche<br>
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Alessandro Barilaro, MD, PhD,
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Valentina Scotti, MD,
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Giorgia Falchetti, MD,
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Enrico Fainardi, MD,
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Marco Moretti, MD and
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Luca Massacesi, MD
<br>1)Commercial entities: Biogen; Novartis; Merck-Serono; <br>Roche;<br><br>Non Profit Entity: European Medicine Agency.<br>
NONE
<<br>1) Commercial entity: Biogen-Idec, speaker honoraria; <br>2) Commercial entity Merck-Serono: travel reimbursments <br>for scientific events; speaker honoraria;<br>3) Commercial entity Genzyme: travel reimbursement for<br>scientific events.<br>4) Commercial entity Roche: speaker honoraria and travel <br>reibursements for scientific events.<br>5) Commercial entity Mylan: travel reimbursment for<br>scientific events; speaker honoraria<br>
NONE
NONE
NONE
NONE
<br>1) Commercial entity Mylan;<br>
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- From the Departments of Neuroscience Drugs and Child Health (F.A., A.F., L.M.) and Experimental and Clinical Biomedical Sciences (E.F.), University of Florence; Neuroimmunology Laboratory (M.G.), IRCCS Mondino Foundation; and Neurology 2 Unit (A.B.), Internal Medicine Unit 2 (V.S., G.F.), and Neuroradiology Unit (E.F., M.M.), Careggi University Hospital, Florence, Italy.
- Correspondence
Dr. Massacesi massacesi{at}unifi.it
Article usage
Cited By...
Letters: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Hemiplegic Migraine Associated With PRRT2 Variations A Clinical and Genetic Study
Dr. Robert Shapiro and Dr. Amynah Pradhan
Related Articles
- No related articles found.